Levetiracetam for epilepsy: an evidence map of efficacy, safety and economic profiles
Zhan-Miao Yi,1–3 Cheng Wen,1,2 Ting Cai,4 Lu Xu,4 Xu-Li Zhong,5 Si-Yan Zhan,4,6 Suo-Di Zhai1,3 1Department of Pharmacy, Peking University Third Hospital, Beijing, China; 2Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Science, Peking University Healt...
Main Authors: | Yi ZM, Wen C, Cai T, Xu L, Zhong XL, Zhan SY, Zhai SD |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-12-01
|
Series: | Neuropsychiatric Disease and Treatment |
Subjects: | |
Online Access: | https://www.dovepress.com/levetiracetam-for-epilepsy-an-evidence-map-of-efficacy-safety-and-econ-peer-reviewed-article-NDT |
Similar Items
-
Levetiracetam – epilepsy treatment, pharmacokinetics, mechanism of action, interaction and toxicity
by: Piotr Kozłowski, et al.
Published: (2015-04-01) -
The Efficacy of Lamotrigine and Levetiracetam Therapy on Serum Lipid Profile in Epilepsy Patients
by: Özden Kamışlı, et al.
Published: (2011-01-01) -
Efficacy and Tolerability of Intravenous Levetiracetam in Children
by: Jose eAceves, et al.
Published: (2013-08-01) -
The Honeymoon Effect in Adult Patients with Refractory Partial-Onset Epilepsy Under Levetiracetam Add-on Treatment
by: Gülnihal KUTLU, et al.
Published: (2013-01-01) -
Clinical Pharmacology and Pharmacokinetics of Levetiracetam
by: Chanin Clark Wright, et al.
Published: (2013-12-01)